• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Global Flow Cytometry Services Market worth $ 1.5 Billion by 2030 – Exclusive Report by InsightAce Analytic

Share:

September 19, 2022

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Flow Cytometry Services Market- by Accreditation Types (Government and Third-Party Accreditations), Services Types (Type of General Flow Cytometric Services, Type of Analysis based Flow Cytometric Services and Other types of Flow Cytometric Services), Trends, Industry Competition Analysis, Revenue and Forecast To 2030.”

According to the latest research by InsightAce Analytic, the global Flow Cytometry Services market is valued at US$ 876.33 Million in 2021, and it is expected to reach US$ 1.5 Billion by 2030, with a CAGR of 6.21% during a forecast period of 2022-2030.

Flow cytometry is an efficient laboratory method for characterizing the cell population’s physical and fluorescent properties in heterogeneous suspension. This is accomplished with equipment that sends a single stream of cells past a light source while measuring the energy dispersed and emitted at various wavelengths. Cell cycle, cell proliferation, cell viability, cell phenotyping, cell signaling, micronucleus test, and intracellular cytokine production have all been observed using cell cytometry, which offers quick, accurate, and high output cell analysis. Flow cytometry services include specimen preparation, experimental design, acquisition, and data analysis to support biotech, pharmaceutical companies, and researchers in developing new drugs. The market for flow cytometry consists of tools, software, reagents, and related services.

Due to the surge in the number of targeted research projects on chronic illnesses, there is a significant demand for innovative and quick analytical tools to comprehend the disease morphology better. The use of flow cytometry service technology in this context has increased significantly. However, this method requires employing sophisticated, pricey equipment that highly qualified experts must control. Most small and mid-sized players lack the finances to make such extravagant investments. Due to the reliance on specialized contract service providers to handle different aspects of flow cytometry-related activities, outsourcing has become the preferred operational model for innovators in flow cytometry. Technological advancements and widespread adoption in numerous research and diagnostic applications are driving the growth of the flow cytometry service market size. Additionally, the introduction of flow cytometry technology in cutting-edge fields of study, including cytogenetics, proteomics, and marine biology, has increased the market share for flow cytometry services.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

North America is anticipated to be the major contributor to the Flow Cytometry Services market over the forecast years due to the rapid development of technology, growth in R&D spending, expansion of the patent pool, and increase in application volume. Additionally, the Asia Pacific regional market is anticipated to grow significantly during the anticipated period. Large multinational firms outsourcing their research processes to CROs in the Asia-Pacific area are mostly to blame for this. In addition, the growing demand for advanced healthcare facilities and the prevalence of chronic diseases like cancer and HIV are predicted to spur expansion in the flow cytometry services sector.

Major market players operating in the Flow Cytometry Services market include FlowMetric Life Sciences, Flow Contract Sites Laboratory, Bio-Legend, Q2 Solutions, ProImmune, MLM Medical Labs, Unilabs, Firalis, Agilex Biolabs, ACROBIOsystems, Ardena, Life Science Research, Cell flow cytometry, Research Lab Services, Fluorescence, CHOP Research Institute, Bio-Rad Laboratories, Plant Cytometry services, Aurelia Bioscience, Proimmune, Sphere Fluidics Limited, Iconplc, Beakman Coulter, IBR Inc., FACS Servies, Flow Contract side Laboratory, Rockland-inc, NeoGenomics, Charles River Laboratories, ProMab, RayBiotech, Creative Proteomics, ACM Global Laboratories, Covance, ReachBio, Mdbiosciences, CSI Laboratories, Other Prominent Players.

Read more here

Source: Einnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • The Global Contraceptives Market to Garner a Value of US$ 37,242.7 Mn By 2025-EndThe Global Contraceptives Market to Garner a Value of US$ 37,242.7 Mn By 2025-End
  • Elevance Health Acquires Specialty Pharmacy Company BioPlusElevance Health Acquires Specialty Pharmacy Company BioPlus
  • GE Healthcare Unveils Medical Device Cybersecurity Offering for HospitalsGE Healthcare Unveils Medical Device Cybersecurity Offering for Hospitals
  • Augmedics Strengthens AR/AI Portfolio With Planned Acquisition of Surgalign Digital Health AssetsAugmedics Strengthens AR/AI Portfolio With Planned Acquisition of Surgalign Digital Health Assets
  • IBA Sells Radiomed, Part of Iba Dosimetry, to IZI Medical ProductsIBA Sells Radiomed, Part of Iba Dosimetry, to IZI Medical Products
  • Pakistani Online Pharmacy Dawaai Nets $8.5M in Latest Funding Round to Scale Supply ChainPakistani Online Pharmacy Dawaai Nets $8.5M in Latest Funding Round to Scale Supply Chain
  • Varian Completes Acquisition of Cancer Treatment Services InternationalVarian Completes Acquisition of Cancer Treatment Services International
  • Sun Genomics and Dexafit Partner to Integrate Gut Health TestingSun Genomics and Dexafit Partner to Integrate Gut Health Testing

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications